Effect of Fluticasone on Neuropeptides in Nasal Lavage in ... - JIACI
Recommend Documents
growth ratio and nasolabial angle were indirectly measured using ... nasal width to intercanthal distance, columellar width to nasal width, and the nasolabial.
Nasal Lavage (NL) allows non-invasive repeated sampling of airway .... they differ in applied volumes and retention time. Diagnostic NL ..... obtained sinonasal mucosal tissue from CF patients with NP had ..... J Cyst Fibros 2010;9(5):346-50.
Oct 2, 2014 -
Note: if you opt to annotate the file with software other than Adobe ... or revision of any artwork, please consult http://www.elsevier.com/artworkinstructions.
SensorMedics, Yorba Linda, California, USA) and exhaled nitric oxide (eNO) measurements ..... Cai Y, Carty K, Henry RL, Gibson PG. Persistence of sputum.
Reprint requests to: Dr. John C. Ansel, Emory University School of ..... Benrath J, Zimmermann M, Gillardon F: Substance P and nitric oxide mediate would .... Goldsmith PC, Leslie TA, Hayes NA, Levell NJ, Dowd PM, Foreman JC: Inhibitors of.
ABSTRACT: Exacerbations of chronic obstructive pulmonary disease (COPD) ... in Obstructive Lung Disease in Europe (ISOLDE) study in COPD showed a 26%.
neurokinin A in asthma. J. Van Schoor, G.F. Joos, R.A. Pauwels. Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma.
Effect of Fluticasone on Neuropeptides in Nasal Lavage in ... - JIACI
fluticasone propionate nasal spray. Nasal lavage samples were collected after allergen challenge, and neuropeptides were measured using enzyme-linked ...
ORIGINAL ARTICLE
Effect of Fluticasone on Neuropeptides in Nasal Lavage in Persistent Allergic Rhinitis C Schäper,1 B Gustavus,2 B Koch,1 R Ewert,1 SB Felix,1 G Kunkel,2 O Noga,2 S Gläser1 1
Department of Internal Medicine B – Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, Universität Greifswald, Greifswald, Germany 2 Department of Pneumology and Infectious Diseases, Charité-Universitätsmedizin, Berlin, Germany
■ Abstract Objective: Recent guidelines reveal that allergic rhinitis impairs quality of life. Neuropeptides play a central role in allergy-related nasal inflammation. The objective of this study was to analyze the release of neuropeptides (substance P, neurokinin A, and vasoactive intestinal peptide) in nasal lavage and their modification by intranasal fluticasone propionate as an established therapy in patients with allergic rhinitis. Methods: Eleven patients with proven allergic rhinitis induced by house dust mite were challenged before and after administration of fluticasone propionate nasal spray. Nasal lavage samples were collected after allergen challenge, and neuropeptides were measured using enzyme-linked immunosorbent assay. Values for histamine, protein, and human serum albumin were also recorded. Eight healthy individuals were included as nonatopic controls. Results: The neuropeptides investigated were detectable in nasal lavage fluid in both patients and controls. Treatment with fluticasone propionate significantly decreased clinical response to allergen challenge (P